Iridex (IRIX) EPS (Diluted) Growth (3y) (2013 - 2026)
Analysis
Iridex (IRIX) EPS (Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -12.16% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 24.56% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 24.50% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 19.81% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 50.83% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -6.12% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 33.46% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 18.07% |
| 10 | Iridex | 11.85 Mn | 7.17 Mn | 4.30 Mn | 25.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 4, 2026 | 25.03% |
| Apr 4, 2026 | 38.58% |
| Jan 3, 2026 | 27.99% |
| Sep 27, 2025 | 5.77% |
| Jun 28, 2025 | 25.12% |
| Mar 29, 2025 | 12.52% |
| Dec 28, 2024 | 5.28% |
| Sep 28, 2024 | 5.20% |
| Jun 29, 2024 | -57.75% |
| Mar 30, 2024 | -15.01% |
| Sep 30, 2023 | 4.41% |
| Jul 1, 2023 | 5.06% |
| Apr 1, 2023 | -2.94% |
| Dec 31, 2022 | 12.64% |
| Oct 1, 2022 | 5.18% |
| Jul 2, 2022 | 7.34% |
| Apr 2, 2022 | 12.35% |
| Jan 1, 2022 | 30.90% |
| Oct 2, 2021 | 19.03% |
| Jul 3, 2021 | 32.06% |